This Flu Season Killed 172 Kids

Vaccination reduced the risk of death by two-thirds for children with no other health problems.

Written bySukanya Charuchandra
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ISTOCK, PEOPLEIMAGESThe Centers for Disease Control and Prevention’s US influenza survey published on June 8 reports the death of one more child, bringing the current tally to 172. This is the highest number reported since the CDC began registering pediatric deaths, except for the H1N1 pandemic that killed 358 children in 2009.

According to The Washington Post, Daniel Jernigan, head of the CDC’s influenza division, says this season was “bad across the population.” The CDC’s new classification system for flu seasons categorized the 2017-18 flu as “high severity” across all ages. “It was happening to everyone, and it seemed to be happening everywhere,” Jernigan adds.

The CDC concocts a new vaccine every year based on predictions of seasonal strains. Despite the CDC’s flu vaccine recommendations, only 38.8 percent of children between the ages of 6 months and 17 years received the immunization this season.

The flu vaccine “reduced the risk of death among children by half for any kids who had underlying medical conditions, and by nearly two-thirds for otherwise healthy children,” Alicia Bird, an epidemiologist in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies